cbdMD (YCBD) Common Equity (2016 - 2025)

cbdMD (YCBD) has 10 years of Common Equity data on file, last reported at $9.0 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 405.61% year-over-year to $9.0 million; the trailing twelve-month figure through Dec 2025 stood at $9.0 million (up 405.61% YoY), and the FY2025 full-year result was $7.2 million, up 268.04% from the prior year.
• Common Equity improved to $9.0 million in Q4 2025, from $7.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $103.1 million in Q3 2021 to a low of $665798.0 in Q1 2025.
• A 5-year average of $32.4 million and a median of $9.0 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity plunged 88.23% in 2024 and surged 405.61% in 2025, its largest moves.
• Tracing YCBD's Common Equity over 5 years: stood at $84.4 million in 2021, then sank by 68.49% to $26.6 million in 2022, then slumped by 73.54% to $7.0 million in 2023, then slumped by 74.68% to $1.8 million in 2024, then surged by 405.61% to $9.0 million in 2025.
• Business Quant data shows YCBD's Common Equity at $9.0 million in Q4 2025, $7.2 million in Q3 2025, and $6.1 million in Q2 2025.